Triumvira Immunologics, Inc.

📍 Austin, United States🗓 Founded 2015👥 70 employees💰 Last funded Mar 2022
Biotechnology Research🌐 triumvira.com
Website LinkedIn
At Triumvira Immunologics, Inc., our team is dedicated to a vision of finding a cure and providing new hope for patients with life-threatening disease. Co-founded in 2015 by licensing technology out of McMaster University and Bloom Burton & Co., Triumvira is working to achieve this vision by developing a proprietary T cell Antigen Coupler (TAC) technology, thought to be safer and more efficacious than current cancer treatments including chimeric antigen receptor (CAR) and engineered T cell receptor (TCR) therapies. We are an emergent US company with operations in the United States and Canada. We bring together talent from a wide range of disciplines including immunobiology, drug development, fundraising, commercialization and finance, with decades of experience across big pharma and small biotech, multiple industries and academia. We are passionate about science that pushes the limits, the patients that drive the heart of our work, and the wellness of our employees. We embrace flexibility. If you are looking for a career where you are encouraged to be innovative, challenge the status quo, and have some fun while doing it, Triumvira is the place for you. For more information about Triumvira career opportunities, please see our Careers web page at: https://triumvira.com/contact-us/careers/
5
Total investors
0
Early stage
2
Mid stage
3
Late stage
2015
Founded

Investors

5 investors
All
Early stage
Mid stage
Late stage
Investor geography3 countries
United States
3
Switzerland
1
Cyprus
1
Investor activity2018–2022 · investors recorded per year
20181202012021120222
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Triumvira Immunologics, Inc.?
Triumvira Immunologics, Inc. has 5 investors on record on gritt.io, 2 mid-stage and 3 late-stage investors.
When did Triumvira Immunologics, Inc. last raise funding?
The most recent investment in Triumvira Immunologics, Inc. recorded on gritt.io was in March 2022.
When was Triumvira Immunologics, Inc. founded?
Triumvira Immunologics, Inc. was founded in 2015.
What industry is Triumvira Immunologics, Inc. in?
Triumvira Immunologics, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Triumvira Immunologics, Inc. based?
Triumvira Immunologics, Inc. is headquartered in Austin, United States.